Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technology makes clinical research more precise

12.12.2006
The Flanders Interuniversity Institute for Biotechnology (VIB) and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans.

The collaboration between VIB and AlgoNomics has yielded a biological test that supplements the current computer simulations. The additional data enable a more precise determination of the immune response. This knowledge is important for the development of new medicines, because it indicates that a new therapeutic substance is ready to be tested on humans.

T-cells, essential agents of our immune system

The immune system is our defense against foreign intruders, such as viruses and bacteria. It reacts against everything that it recognizes as ‘foreign to the body’ - but, therefore, it might also react against certain substances that researchers want to develop into therapeutic drugs. An important trigger of the immune system’s response is the activation of T-cells, a particular type of white blood cell. The T-cells produce cytokines, substances that signal the other cells of the immune system to take action.

Developing therapeutic proteins

In the development of new therapeutic proteins, it is extremely important to know whether or not the proteins induce an immune response. When you suspect that a certain substance has a therapeutic effect, it must not be destroyed by your immune system, or induce other immune responses, because you want the substance to be able to do its beneficial work.

On the other hand, when developing a vaccine, you do want it to induce an immune response - that is, a reaction that does not make you sick but that protects you against future contact with the disease that the vaccine combats.

Epibase, an ‘in silico’ test

For quite some time now, AlgoNomics has been offering Epibase to companies that are developing therapeutic proteins and that want to know whether their product induces an immune response. On the basis of a sophisticated computer program, Epibase can predict whether or not a particular protein will trigger the activation of T-cells. The technology can do this for all proteins, whether they originate from humans or from another biological source, such as a virus or a cancer cell. The marvelous thing about Epibase is that it can also do this for proteins for which little or no experimental data are available. Other technologies require at least a minimum of data to predict whether a substance induces an immune response or not. Epibase has already been used for the development of a variety of therapeutic proteins and is currently the biotech industry standard. In contrast to other ‘in silico’ platforms, Epibase provides greater precision and can predict immune response in Asian and South American populations as well.

A more complete test

Upon the request of AlgoNomics, VIB scientists connected with Ghent University, under the direction of Johan Grooten, have designed a biological test that supplements the Epibase assessments with certain experimental data. The test exposes blood cells - which include T-cells - to the proteins under study. If the proteins being investigated induce an immune response, the T-cells will become active and produce cytokines. In this new test, the activity of the T-cells is measured by determining the quantity of cytokines that are produced.

The new test allows scientists to examine a biological system to see whether a substance induces an immune response. For the step to a clinical phase (and thus tests on humans), the experimental and ‘in silico’ data are both needed to assess the risk of inducing an immune response. Thanks to the collaboration between VIB and AlgoNomics, it is now possible to generate all the data by means of a single test - an artful combination of ‘in silico’ and ‘in vitro’ work.

Sooike Stoops | alfa
Further information:
http://www.vib.be

Further reports about: AlgoNomics Epibase T-Cells immune immune response induce silico’ therapeutic

More articles from Life Sciences:

nachricht How brains surrender to sleep
23.06.2017 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH

nachricht A new technique isolates neuronal activity during memory consolidation
22.06.2017 | Spanish National Research Council (CSIC)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>